The American College of Rheumatology and the European Alliance of Associations for Rheumatology have published recommendations for diagnosing, managing, and treating type 1 interferonopathies like Aicardi-Goutieres Syndrome. The AGSAA’s own Devon Cordova participated in this working group that brought experts together to review literature, consider patient perspectives, and publish recommendations for a group of rare diseases that includes AGS.
